Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Ozkaya S., Findik S., Uzun O., Atici A. G., Erkan L.

CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, cilt.2, 2008 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 2
  • Basım Tarihi: 2008
  • Dergi Adı: CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Anahtar Kelimeler: non-small cell lung cancer, median survival, cisplatin, gemcitabine, vinorelbine, toxicity, RANDOMIZED PHASE-III, SUPPORTIVE CARE, COMBINATION CHEMOTHERAPY, PLUS CISPLATIN, TRIAL, MITOMYCIN, POLYCHEMOTHERAPY, IFOSFAMIDE, VINDESINE, SURVIVAL
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Purpose: The objective of this trial was to compare cisplatin-plus-vinorelbine regimen with cisplatin-plus-gemcitabine regimen in patients with stage IIIB-IV non-small cell lung cancer (NSCLC).